{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T21:11:07Z","timestamp":1790111467350,"version":"4.0.1"},"reference-count":20,"publisher":"Public Library of Science (PLoS)","issue":"10","license":[{"start":{"date-parts":[[2020,10,19]],"date-time":"2020-10-19T00:00:00Z","timestamp":1603065600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0240687","type":"journal-article","created":{"date-parts":[[2020,10,19]],"date-time":"2020-10-19T17:32:56Z","timestamp":1603128776000},"page":"e0240687","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":8,"title":["Medical management of muscle weakness in Duchenne muscular dystrophy"],"prefix":"10.1371","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7154-2585","authenticated-orcid":true,"given":"Sarah R.","family":"Rivera","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sumit K.","family":"Jhamb","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hoda Z.","family":"Abdel-Hamid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gyula","family":"Acsadi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Brandsema","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emma","family":"Ciafaloni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Basil T.","family":"Darras","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan T.","family":"Iannaccone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chamindra G.","family":"Konersman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nancy L.","family":"Kuntz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Craig M.","family":"McDonald","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julie A.","family":"Parsons","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carolina","family":"Tesi Rocha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Craig M.","family":"Zaidman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8452-7189","authenticated-orcid":true,"given":"Russell J.","family":"Butterfield","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne M.","family":"Connolly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katherine D.","family":"Mathews","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2020,10,19]]},"reference":[{"issue":"2","key":"pone.0240687.ref001","first-page":"121","article-title":"Improvement of survival in Duchenne Muscular Dystrophy: retrospective analysis of 835 patients","volume":"31","author":"L Passamano","year":"2012","journal-title":"Acta Myol"},{"issue":"1","key":"pone.0240687.ref002","doi-asserted-by":"crossref","first-page":"47","DOI":"10.3233\/JND-170272","article-title":"Long-Term Pulmonary Function in Duchenne Muscular Dystrophy: Comparison of Eteplirsen-Treated Patients to Natural History","volume":"5","author":"TB Kinane","year":"2018","journal-title":"J Neuromuscul Dis"},{"issue":"1","key":"pone.0240687.ref003","doi-asserted-by":"crossref","first-page":"31","DOI":"10.3233\/JND-180346","article-title":"Management of Adrenal Insufficiency Risk After Long-term Systemic Glucocorticoid Therapy in Duchenne Muscular Dystrophy: Clinical Practice Recommendations","volume":"6","author":"SA Bowden","year":"2019","journal-title":"J Neuromuscul Dis"},{"key":"pone.0240687.ref004","unstructured":"What Is Duchenne Muscular Dystrophy? duchenneuk 2020 [cited 2020 Feb 4];Available from: URL: https:\/\/www.duchenneuk.org\/faqs\/what-is-duchenne-muscular-dystrophy."},{"issue":"10119","key":"pone.0240687.ref005","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/S0140-6736(17)32160-8","article-title":"Long-term effects of glucocorticoids on function, quality of life, and survival in patients with Duchenne muscular dystrophy: a prospective cohort study","volume":"391","author":"CM McDonald","year":"2018","journal-title":"Lancet"},{"issue":"4","key":"pone.0240687.ref006","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1002\/mus.24346","article-title":"Outcome reliability in non-ambulatory boys\/men with Duchenne muscular dystrophy","volume":"51","author":"AM Connolly","year":"2015","journal-title":"Muscle Nerve"},{"issue":"5","key":"pone.0240687.ref007","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1212\/WNL.0000000000002337","article-title":"Practice guideline update summary: Corticosteroid treatment of Duchenne muscular dystrophy: Report of the Guideline Development Subcommittee of the American Academy of Neurology","volume":"86","author":"D Gloss","year":"2016","journal-title":"Neurology"},{"issue":"5","key":"pone.0240687.ref008","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/S1474-4422(18)30026-7","article-title":"Diagnosis and management of Duchenne muscular dystrophy, part 3: primary care, emergency management, psychosocial care, and transitions of care across the lifespan","volume":"17","author":"DJ Birnkrant","year":"2018","journal-title":"Lancet Neurol"},{"issue":"4","key":"pone.0240687.ref009","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/S1474-4422(18)30025-5","article-title":"Diagnosis and management of Duchenne muscular dystrophy, part 2: respiratory, cardiac, bone health, and orthopaedic management","volume":"17","author":"DJ Birnkrant","year":"2018","journal-title":"Lancet Neurol"},{"issue":"3","key":"pone.0240687.ref010","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/S1474-4422(18)30024-3","article-title":"Diagnosis and management of Duchenne muscular dystrophy, part 1: diagnosis, and neuromuscular, rehabilitation, endocrine, and gastrointestinal and nutritional management","volume":"17","author":"DJ Birnkrant","year":"2018","journal-title":"Lancet Neurol"},{"issue":"6","key":"pone.0240687.ref011","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1212\/WNL.0000000000000669","article-title":"The burden of Duchenne muscular dystrophy: an international, cross-sectional study","volume":"83","author":"E Landfeldt","year":"2014","journal-title":"Neurology"},{"issue":"11","key":"pone.0240687.ref012","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1161\/CIRCULATIONAHA.117.028382","article-title":"Mutation-Based Therapy for Duchenne Muscular Dystrophy: Antisense Treatment Arrives in the Clinic","volume":"136","author":"EM McNally","year":"2017","journal-title":"Circulation"},{"key":"pone.0240687.ref013","unstructured":"Prescribing Information (Exondys 51). Access Data 2016 September 1 [cited 2019 Dec 18];Available from: URL: https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2016\/206488lbl.pdf."},{"key":"pone.0240687.ref014","unstructured":"Sarepta Therapeutics. Realizing the potential of RNA-based Technology. JP Morgan Healthcare Conference 2014 [cited 2019 Dec 18];Available from: URL: https:\/\/www.sec.gov\/Archives\/edgar\/data\/873303\/000119312515007220\/d850728dex991.htm."},{"key":"pone.0240687.ref015","unstructured":"Iff J., Charles Gerrits, Gautam Sajeev, James Signorovitch, Edward Tuttle. Eteplirsen Delays Time to Loss of Ambulation in Patients With Duchenne Muscular Dystrophy Compared With Patients Receiving Standard of Care. Muscular Dystrophy Association Clinical and Scientific Conference. 2019. 12-18-2019."},{"key":"pone.0240687.ref016","doi-asserted-by":"crossref","unstructured":"Alfano L.N. Effects of Long-Term Eteplirsen Treatment on Upper Limb Function in Patients With Duchenne Muscular Dystrophy: Findings of Two Phase 2 Clinical Trials. International Annual Congress of the World Muscle Society. 2017. 12-18-2019.","DOI":"10.1016\/j.nmd.2017.06.439"},{"key":"pone.0240687.ref017","unstructured":"Sarepta Therapeutics Announces FDA Approval of VYONDYS 53\u2122 (golodirsen) Injection. Sarepta Therapeutics 2019 December 12 [cited 2020 Jan 9];Available from: URL: https:\/\/investorrelations.sarepta.com\/static-files\/15f0244f-6c99-42de-9919-30e801049ee0."},{"key":"pone.0240687.ref018","unstructured":"FDA grants accelerated approval to first targeted treatment for rare Duchenne muscular dystrophy mutation. FDA gov 2019 December 12 [cited 2020 Sep 1];Available from: URL: https:\/\/www.fda.gov\/news-events\/press-announcements\/fda-grants-accelerated-approval-first-targeted-treatment-rare-duchenne-muscular-dystrophy-mutation."},{"key":"pone.0240687.ref019","unstructured":"FDA. Vyondys 53 (Accelerated Approval). U S Food & Drug Administration 2020 [cited 2020 Jan 20];Available from: URL: https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/appletter\/2019\/211970Orig1s000ltr.pdf."},{"issue":"21","key":"pone.0240687.ref020","doi-asserted-by":"crossref","first-page":"e2270","DOI":"10.1212\/WNL.0000000000009233","article-title":"Increased dystrophin production with golodirsen in patients with Duchenne muscular dystrophy","volume":"94","author":"DE Frank","year":"2020","journal-title":"Neurology"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0240687","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,10,19]],"date-time":"2020-10-19T17:33:28Z","timestamp":1603128808000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0240687"}},"subtitle":[],"editor":[{"given":"Alfio","family":"Spina","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2020,10,19]]},"references-count":20,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2020,10,19]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0240687","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,10,19]]}}}